Solventum Corp (SOLV)
Health Care / Health Care Technology
S&P 500$70.99
Below average on several measures. Research carefully.
Weak
Score based on 4 of 5 models — moderate confidence
Is Solventum Corp a Good Investment in 2026?
Solventum Corp (SOLV) scores 4.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates Solventum Corp as Strong (Top 10% (rank 7%)). However, the Lynch model rates it Caution. Solventum Corp ranks #745 out of 1126 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 8x earnings — near sector median of 26x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Neutral
Business quality & competitive moat
Graham
Caution
9% below fair value
Lynch
Caution
Growth rate vs price (PEG)
Greenblatt
Strong
Top 10% (rank 7%)
Frequently Asked Questions
Is Solventum Corp (SOLV) a good investment?
What is Solventum Corp's Piotroski F-Score?
Is SOLV overvalued or undervalued?
How does SOLV compare to other Health Care stocks?
What do investment models say about SOLV?
Similar Stocks
Compare SOLV with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer